Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

Why Do Drug Shortages Happen in Canada? 6 Real Reasons Explained

Published August 13, 2026 · Updated September 16, 2026 · 5 min read

Quick answer

Most Canadian drug shortages trace back to problems somewhere in the global manufacturing and supply chain, not a lack of demand or a uniquely Canadian issue. Common causes include manufacturing disruptions, raw material shortages, and Canada being a relatively small market compared to the countries that get priority when global supply is tight.

Manufacturing and quality problems

A production line issue, an equipment failure, or a quality or regulatory hold at a manufacturing facility can halt output of a drug with little advance warning. These issues are rarely specific to Canada — they affect every market the facility supplies.

Raw material and active ingredient shortages

Most drugs are made from active pharmaceutical ingredients (APIs) sourced from a small number of specialized suppliers, often overseas. If one of those suppliers has a disruption, every manufacturer that depends on them can be affected at once — even if the manufacturers themselves are otherwise running normally.

Single-source products

Some drugs, especially older or lower-profit ones, are made by only one manufacturer for the entire Canadian market. When that single manufacturer has any disruption, there's no second supplier to fall back on — which is part of why single-source drugs are more likely to end up as Tier 3, the most severe shortage classification.

Sudden demand spikes

Occasionally demand for a drug rises faster than manufacturers planned for — for example, when a drug becomes newly popular for an additional use. Manufacturing capacity typically takes time to scale up, so a sharp demand increase can outpace supply even without any production problem.

Canada's place in the global supply chain

Canada is a comparatively small pharmaceutical market next to the United States, the EU, and other major markets. When a global manufacturer has to ration limited supply across countries, Canada doesn't always get the same priority as larger markets — which can turn a global supply constraint into a more visible shortage here.

Business decisions — not the same as a shortage

Sometimes a manufacturer simply stops making a product because it's no longer commercially viable for them. That's a discontinuation, not a shortage, and it calls for a different response. See Drug Shortage vs Discontinued: What's the Difference? to tell the two apart.

Related Guides

Latest Canadian Shortage Updates

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

40MG 10MG · DIN 02371030

Resolved

Updated: 2026-09-28

AURO PHARMA INC

80MG · DIN 02533243

Active Shortage

Updated: 2026-09-25

AURO PHARMA INC

25MG 160MG · DIN 02408139

Active Shortage

Updated: 2026-09-25

APOTEX INC

100MG · DIN 02245663

Active Shortage

Updated: 2026-09-25

Guide last reviewed September 16, 2026. MedShort.ca is an independent tracking tool and does not provide medical advice.